ImmunoGenesis, Inc. — Form D
ImmunoGenesis, Inc. of Doylestown, PA, a company, filed a Form D exempt-offering notice with the SEC on 2024-04-03. The offering totals $66.5M, of which $44.4M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2024-04-03
- Form: D
- Accession: 0002018057-24-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $66.5M
- Amount sold: $44.4M
- Remaining: $22.1M
- Investors: 88
- Date of first sale: 2024-03-18
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-509426
Issuer
- Name: ImmunoGenesis, Inc.
- CIK: 0002018057
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2019
- Address: 263 North Main St., Apt 417, Doylestown, PA, 18901
- Phone: 3467720336
Officers, directors & promoters (16)
| Name | Role | Location |
|---|
| James Barlow | Director | Scottsdale, AZ |
| Thomas Barton | Director | New York, NY |
| Michael Curran | Director | Houston, TX |
| Robert Stein | Director | Chanhassen, MN |
| Clifford Stocks | Director | Houston, TX |
| James Barlow | Executive Officer | Scottsdale, AZ |
| Jeremy Barton | Executive Officer | Houston, TX |
| Federica O'Brien | Executive Officer | Houston, TX |
| Federica Pericle | Executive Officer | Houston, TX |
| TED KOUTOUZIS | Director | SANTA CLARA, CA |
| Michael A Curran | Director | Doylestown, PA |
| Jennifer Barlow | Director | Doylestown, PA |
| Jennifer Barlow | Executive Officer | Doylestown, PA |
| Clifford B Stocks | Director | Doylestown, PA |
| Thomas A Barton | Director | Doylestown, PA |
| Robert B Stein | Director | New York, NY |
Other filings by this issuer (1)
More